PODD
Insulet Corporation
Price Chart
Latest Quote
$145.76
+2.24 (+1.56%)
Current Price
| Previous Close | $143.52 |
| Open | $144.64 |
| Day High | $146.22 |
| Day Low | $142.10 |
| Volume | 2,864,144 |
Stock Information
| Shares Outstanding | 69.26M |
| Total Debt | $1.01B |
| Cash Equivalents | $480.40M |
| Revenue | $2.90B |
| Net Income | $302.80M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $10.10B |
| P/E Ratio | 33.98 |
| EPS (TTM) | $4.29 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $10.63B |
| Sales | $2.90B |
| Income | $302.80M |
| Book/sh | $18.81 |
| Cash/sh | $6.94 |
| Employees | 5K |
Financial Ratios
| Quick Ratio | 1.49 |
| Current Ratio | 2.49 |
| Debt/Eq | 77.84 |
| EPS Growth TTM | 157.30% |
Returns & Margins
| ROA | 9.74% |
| ROE | 23.00% |
| Gross Margin | 71.01% |
| Operating Margin | 16.03% |
| Profit Margin | 10.44% |
Ownership
| Insider Ownership | 0.33% |
| Institutional Ownership | 105.54% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 18.04 |
| PEG | 1.29 |
| P/S | 3.48 |
| P/B | 7.75 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $242.43 |
Technical Indicators
| SMA20 | $148.92 |
| SMA50 | $165.09 |
| SMA200 | $256.42 |
| RSI | 50.84 |
| ATR | 6.5079 |
| Shares Float | 68.99M |
| Short Float | 6.90% |
| Short Ratio | 2.20 |
| Volatility | 1.12 |
| Rel Volume | 1.81 |
Performance History
| Week | -2.30% |
| Month | -5.72% |
| Quarter | -36.25% |
| 6 Months | -49.52% |
| YTD | -48.48% |
| Year | -52.11% |
| 3 Years | -48.22% |
| 5 Years | -48.39% |
| 10 Years | +391.27% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $145.76 | 2,864,000 |
| 2026-06-17 | $143.52 | 1,542,200 |
| 2026-06-16 | $147.69 | 942,300 |
| 2026-06-15 | $148.14 | 1,041,200 |
| 2026-06-12 | $149.70 | 992,600 |
| 2026-06-11 | $149.19 | 1,501,800 |
| 2026-06-10 | $150.71 | 1,477,500 |
| 2026-06-09 | $159.61 | 1,820,000 |
| 2026-06-08 | $151.51 | 1,569,600 |
| 2026-06-05 | $153.22 | 2,307,300 |
| 2026-06-04 | $146.41 | 1,410,400 |
| 2026-06-03 | $143.30 | 1,140,800 |
| 2026-06-02 | $142.43 | 1,121,000 |
| 2026-06-01 | $148.13 | 1,316,200 |
| 2026-05-29 | $144.94 | 2,077,900 |
| 2026-05-28 | $142.65 | 2,676,900 |
| 2026-05-27 | $146.01 | 2,507,700 |
| 2026-05-26 | $153.80 | 1,302,600 |
| 2026-05-22 | $154.87 | 949,100 |
| 2026-05-21 | $156.89 | 1,031,600 |
| 2026-05-20 | $156.59 | 1,129,100 |
| 2026-05-19 | $154.61 | 1,390,900 |
About Insulet Corporation
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
đ° Latest News
Bank of America Securities Maintains Buy Rating on Insulet (PODD) Stock
Insider Monkey âĸ 2026-06-21T11:19:31Z
Insulet (PODD) Announces Positive Clinical Trial Results for Next-Generation Omnipod 6 AID System
Insider Monkey âĸ 2026-06-19T23:57:52Z
Insulet Corporation Stock: Is PODD Underperforming the Healthcare Sector?
Barchart âĸ 2026-06-19T16:08:46Z
If Youâre Looking for the âNext Big Thingâ Before the OpenAI and Anthropic IPOs, Try This Barchart Stock Screener
Barchart âĸ 2026-06-15T18:38:40Z
2 S&P 500 Stocks to Target This Week and 1 That Underwhelm
StockStory âĸ 2026-06-15T12:44:07Z
Is Insulet Corporation (PODD) A Good Stock To Buy Now?
Insider Monkey âĸ 2026-06-11T20:26:46Z
Assessing Insulet (PODD) Valuation After New Omnipod Clinical Data And System Updates
Simply Wall St. âĸ 2026-06-11T11:08:00Z
Insulet (PODD) Enhances Omnipod 5 System with New Target Glucose Option
Insider Monkey âĸ 2026-06-08T03:44:35Z
Why Is Insulet (PODD) Down 8.7% Since Last Earnings Report?
Zacks âĸ 2026-06-05T15:30:26Z
Dexcom buys Nutrisense; Insulet rolls out patch pump update
MedTech Dive âĸ 2026-06-05T10:25:38Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $768,200,000 | $625,900,000 | $537,200,000 | $499,700,000 |
| Cost Of Revenue | $768,200,000 | $625,900,000 | $537,200,000 | $499,700,000 |
| Total Revenue | $2,708,100,000 | $2,071,600,000 | $1,697,100,000 | $1,305,300,000 |
| Operating Revenue | $2,708,100,000 | $2,071,600,000 | $1,697,100,000 | $1,305,300,000 |
| Expenses | ||||
| Interest Expense | $59,400,000 | $42,700,000 | $36,200,000 | $36,000,000 |
| Total Expenses | $2,234,300,000 | $1,762,700,000 | $1,477,000,000 | $1,267,700,000 |
| Other Income Expense | $-109,600,000 | $-5,500,000 | $2,200,000 | $-1,100,000 |
| Other Non Operating Income Expenses | $1,800,000 | $-5,500,000 | $2,200,000 | $-1,100,000 |
| Net Non Operating Interest Income Expense | $-24,700,000 | $-3,200,000 | $-7,600,000 | $-26,700,000 |
| Interest Expense Non Operating | $59,400,000 | $42,700,000 | $36,200,000 | $36,000,000 |
| Operating Expense | $1,466,100,000 | $1,136,800,000 | $939,800,000 | $768,000,000 |
| Total Other Finance Cost | - | - | - | $4,300,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $247,100,000 | $418,300,000 | $206,300,000 | $4,600,000 |
| Net Interest Income | $-24,700,000 | $-3,200,000 | $-7,600,000 | $-26,700,000 |
| Interest Income | $34,700,000 | $39,500,000 | $28,600,000 | $9,300,000 |
| Normalized Income | $328,180,825 | $418,300,000 | $206,300,000 | $4,600,000 |
| Net Income From Continuing And Discontinued Operation | $247,100,000 | $418,300,000 | $206,300,000 | $4,600,000 |
| Total Operating Income As Reported | $473,800,000 | $308,900,000 | $220,100,000 | $37,600,000 |
| Average Dilution Earnings | $3,000,000 | $9,100,000 | $10,400,000 | - |
| Net Income Common Stockholders | $247,100,000 | $418,300,000 | $206,300,000 | $4,600,000 |
| Net Income | $247,100,000 | $418,300,000 | $206,300,000 | $4,600,000 |
| Net Income Including Noncontrolling Interests | $247,100,000 | $418,300,000 | $206,300,000 | $4,600,000 |
| Net Income Continuous Operations | $247,100,000 | $418,300,000 | $206,300,000 | $4,600,000 |
| Pretax Income | $339,500,000 | $300,200,000 | $214,700,000 | $9,800,000 |
| Special Income Charges | $-123,900,000 | $0 | $0 | $0 |
| Interest Income Non Operating | $34,700,000 | $39,500,000 | $28,600,000 | $9,300,000 |
| Operating Income | $473,800,000 | $308,900,000 | $220,100,000 | $37,600,000 |
| Gross Profit | $1,939,900,000 | $1,445,700,000 | $1,159,900,000 | $805,600,000 |
| Per Share | ||||
| Diluted EPS | $3.48 | $5.78 | $2.94 | $0.07 |
| Basic EPS | $3.51 | $5.97 | $2.96 | $0.07 |
| Other | ||||
| Tax Effect Of Unusual Items | $-30,319,175 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $600,700,000 | $423,700,000 | $323,700,000 | $109,000,000 |
| Total Unusual Items | $-111,400,000 | $0 | $0 | $0 |
| Total Unusual Items Excluding Goodwill | $-111,400,000 | $0 | $0 | $0 |
| Reconciled Depreciation | $90,400,000 | $80,800,000 | $72,800,000 | $63,200,000 |
| EBITDA (Bullshit earnings) | $489,300,000 | $423,700,000 | $323,700,000 | $109,000,000 |
| EBIT | $398,900,000 | $342,900,000 | $250,900,000 | $45,800,000 |
| Diluted Average Shares | $71,886,000 | $73,890,000 | $73,633,000 | $69,910,000 |
| Basic Average Shares | $70,348,000 | $70,076,000 | $69,751,000 | $69,375,000 |
| Diluted NI Availto Com Stockholders | $250,100,000 | $427,400,000 | $216,800,000 | $4,600,000 |
| Tax Provision | $92,400,000 | $-118,100,000 | $8,300,000 | $5,200,000 |
| Other Special Charges | $123,900,000 | - | - | - |
| Gain On Sale Of Security | $12,500,000 | - | - | - |
| Research And Development | $301,100,000 | $219,600,000 | $205,000,000 | $180,200,000 |
| Selling General And Administration | $1,165,000,000 | $917,200,000 | $734,800,000 | $587,800,000 |
Fetched: 2026-06-17
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $1,346,600,000 | $1,061,600,000 | $582,300,000 | $349,200,000 |
| Total Assets | $3,190,400,000 | $3,087,700,000 | $2,588,200,000 | $2,251,100,000 |
| Total Non Current Assets | $1,276,300,000 | $1,196,400,000 | $1,005,300,000 | $937,100,000 |
| Other Non Current Assets | $205,800,000 | $181,500,000 | $188,200,000 | $210,000,000 |
| Non Current Deferred Assets | $82,400,000 | $141,800,000 | $1,800,000 | - |
| Non Current Deferred Taxes Assets | $82,400,000 | $141,800,000 | $1,800,000 | - |
| Goodwill And Other Intangible Assets | $168,700,000 | $150,000,000 | $150,400,000 | $127,200,000 |
| Other Intangible Assets | $117,100,000 | $98,500,000 | $98,700,000 | $75,500,000 |
| Current Assets | $1,914,000,000 | $1,891,300,000 | $1,582,900,000 | $1,314,000,000 |
| Other Current Assets | $228,300,000 | $142,100,000 | $116,400,000 | $86,900,000 |
| Inventory | $452,600,000 | $430,400,000 | $402,600,000 | $346,800,000 |
| Receivables | $517,000,000 | $365,500,000 | $359,700,000 | $205,600,000 |
| Other Receivables | $5,700,000 | $9,700,000 | $5,700,000 | - |
| Accounts Receivable | $511,300,000 | $355,800,000 | $356,500,000 | $205,600,000 |
| Cash Cash Equivalents And Short Term Investments | $716,100,000 | $953,300,000 | $704,200,000 | $674,200,000 |
| Cash And Cash Equivalents | $716,100,000 | $953,300,000 | $704,200,000 | $674,200,000 |
| Cash Equivalents | $577,400,000 | $819,900,000 | $600,500,000 | $538,100,000 |
| Cash Financial | $138,700,000 | $133,400,000 | $103,700,000 | $136,100,000 |
| Receivables Adjustments Allowances | - | $-1,400,000 | $-2,500,000 | - |
| Restricted Cash | - | - | $0 | $500,000 |
| Allowance For Doubtful Accounts Receivable | - | - | $-2,500,000 | $-2,500,000 |
| Gross Accounts Receivable | - | - | $362,200,000 | $208,100,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $233,100,000 | $426,600,000 | $711,600,000 | $727,600,000 |
| Total Debt | $949,200,000 | $1,379,900,000 | $1,415,800,000 | $1,401,800,000 |
| Long Term Debt And Capital Lease Obligation | $930,800,000 | $1,296,100,000 | $1,366,400,000 | $1,374,300,000 |
| Long Term Debt | $930,800,000 | $1,296,100,000 | $1,366,400,000 | $1,374,300,000 |
| Current Debt And Capital Lease Obligation | $18,400,000 | $83,800,000 | $49,400,000 | $27,500,000 |
| Current Debt | $18,400,000 | $83,800,000 | $49,400,000 | $27,500,000 |
| Other Current Borrowings | - | $96,000,000 | $49,400,000 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $1,675,100,000 | $1,876,100,000 | $1,855,500,000 | $1,774,700,000 |
| Total Non Current Liabilities Net Minority Interest | $995,000,000 | $1,347,700,000 | $1,404,300,000 | $1,410,000,000 |
| Other Non Current Liabilities | $64,200,000 | $51,600,000 | $37,900,000 | $35,700,000 |
| Current Liabilities | $680,100,000 | $528,400,000 | $451,200,000 | $364,700,000 |
| Other Current Liabilities | $113,800,000 | $81,000,000 | $73,600,000 | $50,700,000 |
| Payables And Accrued Expenses | $338,700,000 | $220,700,000 | $206,200,000 | $190,600,000 |
| Payables | $75,000,000 | $19,800,000 | $19,200,000 | $30,800,000 |
| Accounts Payable | $75,000,000 | $19,800,000 | $19,200,000 | $30,800,000 |
| Equity | ||||
| Common Stock Equity | $1,515,300,000 | $1,211,600,000 | $732,700,000 | $476,400,000 |
| Total Equity Gross Minority Interest | $1,515,300,000 | $1,211,600,000 | $732,700,000 | $476,400,000 |
| Stockholders Equity | $1,515,300,000 | $1,211,600,000 | $732,700,000 | $476,400,000 |
| Other Equity Interest | $800,000 | - | - | - |
| Gains Losses Not Affecting Retained Earnings | $12,500,000 | $-13,200,000 | $8,000,000 | $20,000,000 |
| Other Equity Adjustments | $12,500,000 | $-13,200,000 | $8,000,000 | $20,000,000 |
| Retained Earnings | $287,400,000 | $40,300,000 | $-378,000,000 | $-584,300,000 |
| Other | ||||
| Treasury Shares Number | $197,374 | - | - | - |
| Ordinary Shares Number | $70,390,816 | $70,196,031 | $69,907,289 | $69,511,286 |
| Share Issued | $70,588,190 | $70,196,031 | $69,907,289 | $69,511,286 |
| Tangible Book Value | $1,346,600,000 | $1,061,600,000 | $582,300,000 | $349,200,000 |
| Invested Capital | $2,464,500,000 | $2,591,500,000 | $2,148,500,000 | $1,878,200,000 |
| Working Capital | $1,233,900,000 | $1,362,900,000 | $1,131,700,000 | $949,300,000 |
| Total Capitalization | $2,446,100,000 | $2,507,700,000 | $2,099,100,000 | $1,850,700,000 |
| Treasury Stock | $60,400,000 | $0 | - | - |
| Additional Paid In Capital | $1,274,900,000 | $1,184,400,000 | $1,102,600,000 | $1,040,600,000 |
| Capital Stock | $100,000 | $100,000 | $100,000 | $100,000 |
| Common Stock | $100,000 | $100,000 | $100,000 | $100,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Pensionand Other Post Retirement Benefit Plans Current | $209,200,000 | $142,900,000 | $122,000,000 | $95,900,000 |
| Current Accrued Expenses | $263,700,000 | $200,900,000 | $187,000,000 | $159,800,000 |
| Goodwill | $51,600,000 | $51,500,000 | $51,700,000 | $51,700,000 |
| Net PPE | $819,400,000 | $723,100,000 | $664,900,000 | $599,900,000 |
| Accumulated Depreciation | $-432,800,000 | $-362,400,000 | $-293,200,000 | $-234,700,000 |
| Gross PPE | $1,252,200,000 | $1,085,500,000 | $958,100,000 | $834,600,000 |
| Leases | $24,800,000 | $16,400,000 | $16,000,000 | $11,700,000 |
| Construction In Progress | $166,900,000 | $136,600,000 | $137,500,000 | $112,300,000 |
| Machinery Furniture Equipment | $810,400,000 | $693,500,000 | $590,300,000 | $544,200,000 |
| Buildings And Improvements | $233,700,000 | $226,800,000 | $205,300,000 | $163,900,000 |
| Land And Improvements | $16,400,000 | $12,200,000 | $9,000,000 | $2,500,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $193,900,000 | $192,500,000 | $223,800,000 | $183,500,000 |
| Work In Process | $64,600,000 | $81,200,000 | $60,600,000 | $84,200,000 |
| Raw Materials | $194,100,000 | $156,700,000 | $118,200,000 | $79,100,000 |
| Current Provisions | - | - | - | $57,300,000 |
| Other Short Term Investments | - | - | - | - |
Fetched: 2026-06-17
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $349,900,000 | $296,200,000 | $36,500,000 | $-38,300,000 |
| Operating Activities | ||||
| Operating Cash Flow | $569,300,000 | $430,200,000 | $145,700,000 | $119,000,000 |
| Cash Flow From Continuing Operating Activities | $569,300,000 | $430,400,000 | $145,800,000 | $119,000,000 |
| Operating Gains Losses | $111,400,000 | - | - | - |
| Investing Activities | ||||
| Capital Expenditure | $-219,400,000 | $-134,000,000 | $-109,200,000 | $-157,300,000 |
| Investing Cash Flow | $-222,700,000 | $-146,200,000 | $-119,400,000 | $-191,100,000 |
| Cash Flow From Continuing Investing Activities | $-222,600,000 | $-146,200,000 | $-119,400,000 | $-191,100,000 |
| Net Other Investing Changes | $-3,300,000 | - | $-3,000,000 | - |
| Capital Expenditure Reported | $-191,600,000 | $-124,900,000 | $-75,600,000 | $-122,900,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-59,600,000 | $0 | $0 | - |
| Financing Cash Flow | $-595,300,000 | $-28,000,000 | $-13,600,000 | $-40,300,000 |
| Cash Flow From Continuing Financing Activities | $-595,100,000 | $-28,100,000 | $-13,600,000 | $-40,300,000 |
| Net Common Stock Issuance | $-59,600,000 | $0 | $0 | $0 |
| Net Other Financing Charges | - | $-7,500,000 | - | - |
| Issuance Of Capital Stock | - | - | - | $0 |
| Common Stock Issuance | - | - | - | $0 |
| Other | ||||
| Repayment Of Debt | $-1,214,200,000 | $-216,100,000 | $-27,000,000 | $-39,800,000 |
| Issuance Of Debt | $506,100,000 | $175,500,000 | $0 | $0 |
| End Cash Position | $716,100,000 | $953,400,000 | $704,200,000 | $689,700,000 |
| Beginning Cash Position | $953,400,000 | $704,200,000 | $689,800,000 | $806,400,000 |
| Effect Of Exchange Rate Changes | $11,500,000 | $-6,800,000 | $1,800,000 | $-4,300,000 |
| Changes In Cash | $-248,800,000 | $256,000,000 | $12,600,000 | $-112,400,000 |
| Proceeds From Stock Option Exercised | $198,500,000 | $20,100,000 | $26,900,000 | $16,300,000 |
| Common Stock Payments | $-59,600,000 | $0 | $0 | - |
| Net Issuance Payments Of Debt | $-708,100,000 | $-40,600,000 | $-27,000,000 | $-39,800,000 |
| Net Long Term Debt Issuance | $-708,100,000 | $-40,600,000 | $-27,000,000 | $-39,800,000 |
| Long Term Debt Payments | $-1,214,200,000 | $-216,100,000 | $-27,000,000 | $-39,800,000 |
| Long Term Debt Issuance | $506,100,000 | $175,500,000 | $0 | $0 |
| Net Investment Purchase And Sale | $0 | $-12,200,000 | $-7,200,000 | $-7,800,000 |
| Purchase Of Investment | $0 | $-12,200,000 | $-7,200,000 | $-7,800,000 |
| Net Intangibles Purchase And Sale | $-27,800,000 | $-9,100,000 | $-33,600,000 | $-34,400,000 |
| Purchase Of Intangibles | $-27,800,000 | $-9,100,000 | $-33,600,000 | $-34,400,000 |
| Change In Working Capital | $-23,100,000 | $-17,000,000 | $-190,600,000 | $-2,500,000 |
| Change In Payables And Accrued Expense | $209,400,000 | $47,700,000 | $59,300,000 | $135,200,000 |
| Change In Accrued Expense | $160,200,000 | $45,500,000 | $70,300,000 | $137,600,000 |
| Change In Payable | $49,200,000 | $2,200,000 | $-11,000,000 | $-2,400,000 |
| Change In Account Payable | $49,200,000 | $2,200,000 | $-11,000,000 | $-2,400,000 |
| Change In Prepaid Assets | $-81,700,000 | $-21,900,000 | $-42,100,000 | $-36,800,000 |
| Change In Inventory | $-10,600,000 | $-32,400,000 | $-53,600,000 | $-49,100,000 |
| Change In Receivables | $-140,200,000 | $-10,400,000 | $-154,200,000 | $-51,800,000 |
| Changes In Account Receivables | $-140,200,000 | $-10,400,000 | $-154,200,000 | $-51,800,000 |
| Other Non Cash Items | $13,200,000 | $12,000,000 | $8,600,000 | $9,600,000 |
| Stock Based Compensation | $62,700,000 | $69,300,000 | $48,400,000 | $40,900,000 |
| Unrealized Gain Loss On Investment Securities | $0 | $3,900,000 | $-2,600,000 | $0 |
| Provisionand Write Offof Assets | $5,400,000 | $-200,000 | $2,300,000 | $4,200,000 |
| Deferred Tax | $62,200,000 | $-136,900,000 | $500,000 | $-1,000,000 |
| Deferred Income Tax | $62,200,000 | $-136,900,000 | $500,000 | $-1,000,000 |
| Depreciation Amortization Depletion | $90,400,000 | $80,800,000 | $72,800,000 | $63,200,000 |
| Depreciation And Amortization | $90,400,000 | $80,800,000 | $72,800,000 | $63,200,000 |
| Gain Loss On Investment Securities | $-12,500,000 | - | - | - |
| Net Income From Continuing Operations | $247,100,000 | $418,300,000 | $206,300,000 | $4,600,000 |
| Net Business Purchase And Sale | - | $0 | $-3,000,000 | $-26,000,000 |
| Purchase Of Business | - | $0 | $-3,000,000 | $-26,000,000 |
| Interest Paid Supplemental Data | - | - | $49,900,000 | $34,200,000 |
| Income Tax Paid Supplemental Data | - | - | $8,100,000 | $5,500,000 |
| Sale Of Investment | - | - | $0 | $0 |
Fetched: 2026-06-17